BioSpace News Archive

Top-line data from NOX-A12 monotherapy trial plus available safety data from NOX-A12 / Keytruda® combination trial to be presented

New modular continuous processing pilot plant in Germany

Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery

Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach

Cynata Therapeutics Limited is pleased to announce data from a preclinical model demonstrating that its proprietary Cymerus™ mesenchymal stem cells (MSCs) significantly ameliorate the effects of cytokine release syndrome (CRS), a potentially severe and life-threatening adverse reaction to cancer immunotherapy.

Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Patient Recruitment Innovation Award (SPRIA). Sponsor by Acurian, the SPRIA recognizes and honors highly successful innovative patient enrollment initiatives executed by sites.

NOXXON Pharma N.V. announced today that the previously disclosed convertible bonds (see press releases of June 15 and August 1, 2018) have been listed on the Euronext Access market in Paris as notes convertible into NOXXON shares

Carestream Health has started shipping a new version of software for its CARESTREAM OnSight 3D Extremity System (see video link) that offers new standard features as well as optional enhanced metal artifact reduction software that can improve visibility of anatomy around metallic objects.

Tesaro, Inc., an oncology-focused biopharmaceutical company, announced its participation in two upcoming investor conferences.